NeoGenomics adopts new performance-based RSU award agreement form

NEOGENOMICS INC

Culture & Compensation Committee authorized new form of PSU agreement under 2023 Equity Incentive Plan on Feb 16, 2024.
PSUs vest based on Stock Price Growth (20-day trailing average price) and 3-Year Cumulative Revenue goals.
Form filed as Exhibit 10.1; all specific metrics, dates, and participant names remain placeholder brackets.
No individual grants or changes to executive compensation disclosed; purely a template adoption.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.